interest income on investments held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the six months ended June 30, 2022, we had a net income of $10,097,524, which consists of the change in fair value of warrant liabilities of $12,253,670, change in fair value of convertible note of $203,800, interest income on investments held in the Trust Account of $261,959, offset by operating costs of $2,621,905.
For the year ended December 31, 2021, we had a net income of $15,113,643, which consists of the change in fair value of warrants of $22,422,330, interest income on investments held in the trust account of $68,571 and a loss on issuance of private warrants of $3,948,000 offset by operating costs of $3,429,258.
Liquidity Capital Resources
On January 26, 2021, we consummated the Initial Public Offering of 34,500,000 JCIC Units which includes the full exercise by the underwriter of its over-allotment option in the amount of 4,500,000 JCIC Units, at $10.00 per JCIC Unit, generating gross proceeds of $345,000,000 which is described in Note 3. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 9,400,000 JCIC Private Placement Warrants at a price of $1.00 per JCIC Private Placement Warrant in a private placement to the Sponsor, generating gross proceeds of $9,400,000, which is described in Note 4.
For the six months ended June 30, 2022, cash used in operating activities was $497,751. Net income of $10,097,524 was affected by interest earned on investments held in the Trust Account of $261,959, the change in the fair value of the warrant liabilities of $12,253,670 and change in fair value of convertible note of $203,800. Changes in operating assets and liabilities provided $2,124,154 of cash from operating activities.
For the year ended December 31, 2021, cash used in operating activities was $1,752,236. Net income of $15,113,643 was affected by interest earned on investments held in the trust account of $68,571, the change in the fair value of the warrant liability of $22,422,330, loss on initial issuance of private warrants of $3,948,000 and transaction costs associated with the warrants issued at the Initial Public Offering of $1,360,701. Changes in operating assets and liabilities provided $316,321 of cash from operating activities.
As of June 30, 2022 and December 31, 2021, we had marketable securities held in the Trust Account of $345,330,530 (including $330,530 of interest income and realized gains) and $345,068,571 (including approximately $69,000 of interest income and realized gains), respectively, consisting of money market funds invested in U.S. Treasury Bills with a maturity of 185 days or less. We may withdraw interest from the Trust Account to pay taxes, if any. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete our business combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our business combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
As of June 30, 2022 and December 31, 2021, we had cash of $92,169 and $89,920, respectively. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a business combination.
On February 16, 2022 we entered into a $1,500,000 convertible promissory note (“Convertible Note”) with the Sponsor in order to fund working capital deficiencies or finance transaction costs in connection with a
197